Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater
Ajanta Pharma USA Inc
Failed Dissolution Specifications: below specification
1 recall found for Ajanta Pharma USA Inc — September 2026.
The recalls listed below are active notices associated with Ajanta Pharma USA Inc in the FDA, NHTSA, USDA, and CPSC databases. None of the current recalls are classified as urgent. Check the specific lot numbers, model numbers, or production date codes in each notice carefully — a recall typically covers specific production runs, not everything a manufacturer sells.
A manufacturer appearing in the recall database does not indicate an ongoing safety failure. High-volume companies with large product lines naturally appear more frequently. What matters is whether your specific product — identified by lot number, model number, or date code — is included in a recall notice.
Browse all medication recalls →Ajanta Pharma USA Inc
Failed Dissolution Specifications: below specification